Anton Dobrin

10PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyCarbon capture engineering (excl. sequestration)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 21, 2026
CAR T cell-derived TNF is an early determinant of cytokine release syndrome severity.

|Feb 26, 2026
Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction.

Nayan Jain, Yuzhe Shi, Celina May

|Jan 30, 2025
HIV immune evasin Nef enhances allogeneic CAR T cell potency.

Karlo Perica, Ivan S Kotchetkov, Jorge Mansilla-Soto

|Mar 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.

Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi

|Nov 07, 2023
Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function.

Nayan Jain, Zeguo Zhao, Richard P Koche

|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.

Luis A Rojas, Zachary Sethna, Kevin C Soares

Pageof 2

Frequent Collaborators

8 joint publications

Michel Sadelain

3 joint publications

Jorge Mansilla-Soto

3 joint publications

Yuzhe Shi

2 joint publications

Taha Merghoub